Firefly Neuroscience, Inc. (AIFF) - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Firefly Neuroscience, Inc. on August 20, 2024, covering events that occurred on August 19, 2024. The company is incorporated in Delaware and trades on the Nasdaq Capital Market under the symbol AIFF.
Key Financial Metrics
This filing does not contain financial statements, revenue, profit, cash flow, margin, debt, or liquidity data. The report focuses exclusively on corporate governance changes and executive compensation agreements.
Material Changes
- Board Appointments: The Board appointed David Johnson and Stella Vnook as directors effective August 19, 2024.
- Executive Leadership: David Johnson was appointed as Executive Chairman of the Board.
- Committee Changes: Stella Vnook succeeded David DeCaprio on the Audit Committee and Arun Menawat on the Nominating and Corporate Governance Committee. Ms. Vnook also replaced Brian Posner as Chairperson of the Nominating Committee.
- Board Classification: The Board was reclassified into three classes (Class I, II, and III) with staggered terms expiring at the first, second, and third annual meetings of stockholders following the filing date.
Employment Agreement and Compensation
The Company entered into an Employment Agreement with David Johnson effective August 19, 2024. Key terms include:
- Base Salary: $12,500 per month ($150,000 annually), subject to annual review.
- Equity Grant: An award of restricted stock representing 5% of the Company's issued and outstanding common stock on a fully diluted basis. Vesting occurs in two equal tranches at 6 and 12 months, with acceleration upon a change in control or termination without Cause/with Good Reason.
- Performance Bonus: A one-time cash bonus tied to successful financing gross capital proceeds:
- $50,000 for proceeds up to $5,000,000.
- $100,000 for proceeds between $5,000,000 and $10,000,000.
- $150,000 for proceeds exceeding $10,000,000.
- Termination: Requires 30 days' written notice for termination without Cause or voluntary resignation without Good Reason.
Investor Verification Checklist
- Verify the fully diluted share count as of August 19, 2024, to calculate the exact number of shares in the 5% grant to David Johnson.
- Review the full text of the Johnson Employment Agreement (Exhibit 10.1) for specific definitions of "Cause," "Good Reason," and "Change in Control."
- Confirm the Company's current cash position to assess its ability to fund the new executive salary and potential performance bonuses.
- Monitor upcoming financing activities to determine if the performance bonus thresholds are met.